Literature DB >> 19398215

The role of rehabilitation in deep brain stimulation of the subthalamic nucleus for Parkinson's disease: a pilot study.

Cristina Tassorelli1, Simona Buscone, Giorgio Sandrini, Claudio Pacchetti, Anna Furnari, Roberta Zangaglia, Michelangelo Bartolo, Giuseppe Nappi, Emilia Martignoni.   

Abstract

Bilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an efficacious therapeutic option in the treatment of advanced Parkinson's disease (PD). The procedure may be however associated with functional impairment of different types and intensity. In this paper we describe the functional impairments detected in a group of 34 subjects with PD who were submitted to DBS. These patients belonged to a cohort of 75 consecutive PD patients who underwent the surgical procedure. The rehabilitation program included physiotherapy exercises for recovery/maintenance of the range of motion, active exercises, exercises for coordination and proprioception, and walking training based on the use of sensory cues, with daily sessions for a period of 4-8 weeks. The motor examination section of unified Parkinson's disease rating scale (UPDRS-ME) and the functional independence measure (FIM) scores showed a consistent and significant improvement in the patients' motor performances. The reported findings suggest that rehabilitation may play an important role in the correction of specific functional impairments caused by or associated with DBS in PD.

Entities:  

Mesh:

Year:  2009        PMID: 19398215     DOI: 10.1016/j.parkreldis.2009.03.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  8 in total

1.  Bilateral subthalamic stimulation for advanced Parkinson disease: early experience at an Eastern center.

Authors:  Shang-Ming Chiou; Yu-Chin Lin; Ming-Kuei Lu; Chon-Haw Tsai
Journal:  Neurol Sci       Date:  2014-11-14       Impact factor: 3.307

Review 2.  [Long-term care after deep brain stimulation of patients with Parkinson's disease].

Authors:  F Sixel-Döring; G Ebersbach
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

3.  Measures to Evaluate the Effects of DBS on Speech Production.

Authors:  Gary Weismer; Yana Yunusova; Kate Bunton
Journal:  J Neurolinguistics       Date:  2012-03       Impact factor: 1.710

Review 4.  Systematic review of the effectiveness of occupational therapy-related interventions for people with Parkinson's disease.

Authors:  Erin R Foster; Mayuri Bedekar; Linda Tickle-Degnen
Journal:  Am J Occup Ther       Date:  2014 Jan-Feb

Review 5.  Swallowing and deep brain stimulation in Parkinson's disease: a systematic review.

Authors:  Michelle S Troche; Alexandra E Brandimore; Kelly D Foote; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2013-05-28       Impact factor: 4.891

6.  Balance and Gait Improvements of Postoperative Rehabilitation in Patients with Parkinson's Disease Treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS).

Authors:  Kazunori Sato; Noriaki Aita; Yoshihide Hokari; Eriko Kitahara; Mami Tani; Nana Izawa; Kozo Hatori; Ryota Nakamura; Fuyuko Sasaki; Satoko Sekimoto; Takayuki Jo; Genko Oyama; Taku Hatano; Yasushi Shimo; Hirokazu Iwamuro; Atsushi Umemura; Nobutaka Hattori; Toshiyuki Fujiwara
Journal:  Parkinsons Dis       Date:  2019-08-04

7.  Neuromodulation of the cerebellum rescues movement in a mouse model of ataxia.

Authors:  Lauren N Miterko; Tao Lin; Joy Zhou; Meike E van der Heijden; Jaclyn Beckinghausen; Joshua J White; Roy V Sillitoe
Journal:  Nat Commun       Date:  2021-02-26       Impact factor: 14.919

8.  Short-Term Motor Outcomes in Parkinson's Disease after Subthalamic Nucleus Deep Brain Stimulation Combined with Post-Operative Rehabilitation: A Pre-Post Comparison Study.

Authors:  Kazunori Sato; Yoshihide Hokari; Eriko Kitahara; Nana Izawa; Kozo Hatori; Kaoru Honaga; Genko Oyama; Taku Hatano; Hirokazu Iwamuro; Atsushi Umemura; Yasushi Shimo; Nobutaka Hattori; Toshiyuki Fujiwara
Journal:  Parkinsons Dis       Date:  2022-08-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.